These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2736567)

  • 1. Pharmacokinetics of ofloxacin in severe chronic renal failure.
    Bandai H; Tsubakihara Y; Yamato E; Yokoyama K; Okada N; Nakanishi I; Iida N
    Clin Ther; 1989; 11(2):210-8. PubMed ID: 2736567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S; Guay D; Opsahl J; Tack K; Matzke G
    Int J Clin Pharmacol Res; 1991; 11(3):115-21. PubMed ID: 1809697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of ofloxacin administered orally in elderly subjects with bronchial or urinary tract infections].
    Bardin C; Clavier M; Darchis JP; Chauvin M; Veyssier P; Farinotti R
    Therapie; 1992; 47(1):35-9. PubMed ID: 1523592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Garenoxacin pharmacokinetics in subjects with renal impairment.
    Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
    Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital.
    Gogo KO; McLigeyo SO; Bwayo JJ; Mumo JM
    East Afr Med J; 1998 May; 75(5):271-3. PubMed ID: 9746996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
    Nawishy S; Moukhtar I; Sabbour M
    Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nicotine in kidney failure.
    Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
    Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure].
    Tsubakihara Y; Hayashi T; Shoji T; Kitamura E; Okada N; Nakanishi I
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):246-9. PubMed ID: 8196221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ; Ing TS; Soung LS; Daugirdas JT; Hano JE; Gandhi VC
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin.
    Lefèvre G; Duval M; Gauron S; Brookman LJ; Rolan PE; Morris TM; Piraino AJ; Morgan JM; Palmisano M; Close P
    Clin Pharmacol Ther; 1997 Jul; 62(1):50-9. PubMed ID: 9246019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
    Teichert J; Tuemmers T; Achenbach H; Preiss C; Hermann R; Ruus P; Preiss R
    J Clin Pharmacol; 2005 Mar; 45(3):313-28. PubMed ID: 15703366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.
    Viron B; De Meyer M; Le Liboux A; Frydman A; Maillard F; Mignon F; Gaillot J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():95-104. PubMed ID: 2387982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of aminosidine in renal patients with different degrees of renal failure.
    Novarini A; Montanari A; Bruschi G; Rossi E; Borghetti A; Migone L
    Clin Nephrol; 1975 Jul; 4(1):23-4. PubMed ID: 1157346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.